Peter Rossing

180PUBLICATIONS
604CO-AUTHORS
Predictive and prognostic markersSocio-economic developmentCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (180)

|Jul 28, 2026
Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials.

|Jul 10, 2026
Prevalence, incidence, mortality, and years of life lost to diabetes from 1996 to 2024 in Denmark.

|Jul 08, 2026
Efficacy and safety of dapagliflozin in patients receiving dialysis: a post-hoc analysis of the DAPA-CKD trial.

|Jul 03, 2026
Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate.

|Jun 18, 2026
GLP-1 receptor agonists in patients with Type 2 diabetes: cardiorenal protection versus ocular safety.

|Jun 15, 2026
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

Pageof 30

Frequent Collaborators

42 joint publications

Richard Pratley

19 joint publications

Rajiv Agarwal

19 joint publications

Katherine Tuttle

16 joint publications

Viktor Rotbain Curovic